All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study (Q42202767)
Jump to navigation
Jump to search
scientific article published on 28 July 2014
- All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study |
scientific article published on 28 July 2014 |
|
Statements
1 reference
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study (English)
1 reference
Guido Gerken
1 reference
Stanislas Pol
1 reference
Patrick Marcellin
1 reference
Michael Manns
1 reference
Ira M Jacobson
1 reference
Stuart C Gordon
1 reference
Cheng-Yuan Peng
1 reference
Ting-Tsung Chang
1 reference
Gregory T Everson
1 reference
Jeong Heo
1 reference
Boris Yoffe
1 reference
William J Towner
1 reference
Marc Bourliere
1 reference
Sophie Metivier
1 reference
Chi-Jen Chu
1 reference
William Sievert
1 reference
Jean-Pierre Bronowicki
1 reference
Dominique Thabut
1 reference
Youn-Jae Lee
1 reference
Fiona McPhee
1 reference
Justin Kopit
1 reference
Patricia Mendez
1 reference
Misti Linaberry
1 reference
Eric Hughes
1 reference
Stephanie Noviello
1 reference
HALLMARK-DUAL Study Team
1 reference
28 July 2014
1 reference
Identifiers
1 reference